Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 4/20 | 0.54 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.54 |
| ▸ | CYP2C18 | P33260 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | AURKA | O14965 | 1/20 | 0.49 |
| ▸ | DHFR | P00374 | 1/20 | 0.49 |
| ▸ | C1R | P00736 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507082 | 0.83 | NR1I2 (0.51) | CYP2C9CYP2C18C1RCYP2C19CA12 | |
| Sulfadiazine, Silver SCHEMBL16043898 | 0.79 | TSHR (0.49) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL31220001 | 0.78 | CYP2C9 (0.56) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL26488037 | 0.78 | TDP1 (0.53) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL5121845 | 0.77 | MAPT (0.68) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL18560169 | 0.77 | CYP2C9 (0.46) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL2518894 | 0.76 | CA12 (0.71) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL519624 | 0.74 | LMNA (0.59) | CYP2C9TSHRLMNAPKMCA12 | |
| SCHEMBL5121853 | 0.74 | C5AR1 (0.59) | CYP2C9CYP2C8CYP2C18TSHRLMNA | |
| SCHEMBL31219708 | 0.73 | TSHR (0.44) | CYP2C9CYP2C8CYP2C18TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070141096-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. | 2007-06-21 | — | — | US | claimed |
| EP-1119345-A4 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GEN MILLS INC (US) | 2004-06-16 | — | — | EP | claimed |
| US-20020044968-A1 | High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion | GENERAL MILLS, INC. | 2002-04-18 | — | — | US | claimed |
| JP-2002511777-A | — | — | 2002-04-16 | — | — | JP | claimed |
| EP-1119345-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2001-08-01 | — | — | EP | claimed |
| WO-2000021504-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| EP-0935523-A4 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GEN MILLS INC (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| EP-0358105-B1 | Method and apparatus of continuously manufacturing solid pharmaceutical forms | BASF AG (DE) | 1994-03-02 | — | — | EP | claimed |
| EP-0240904-B1 | PROCESS FOR THE PREPARATION OF SOLID PHARMACEUTICAL FORMS | BASF Aktiengesellschaft (DE) | 1992-07-01 | — | — | EP | claimed |
| US-5073379-A | Melts, extrusion, rolling. tablets | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | claimed |
| EP-0358107-A2 | Process for the preparation of pharmaceutical tablets | BASF Aktiengesellschaft (DE) | 1990-03-14 | — | — | EP | claimed |
| EP-0358105-A2 | Method and apparatus of continuously manufacturing solid pharmaceutical forms | BASF Aktiengesellschaft (DE) | 1990-03-14 | — | — | EP | claimed |
| US-4801460-A | N-VINYLPYRROLIDONE POLYMER BINDER | BASF AKTIENGESELLSCHAFT (DE) | 1989-01-31 | — | — | US | claimed |
| EP-0240904-A2 | Process for the preparation of solid pharmaceutical forms | BASF Aktiengesellschaft (DE) | 1987-10-14 | — | — | EP | claimed |
| EP-4713096-A1 | CDK INHIBITOR COMPOUNDS | Aleksia Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238574-A1 | CDK INHIBITOR COMPOUNDS | ALEKSIA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| US-4801460-A | N-VINYLPYRROLIDONE POLYMER BINDER | BASF AKTIENGESELLSCHAFT (DE) | 1989-01-31 | — | — | US | disclosed |
| EP-0240904-A2 | Process for the preparation of solid pharmaceutical forms | BASF Aktiengesellschaft (DE) | 1987-10-14 | — | — | EP | disclosed |